The Beat Goes On: Updates in Atrial Fibrillation Guidelines

NOTE: This session is part of the Live Intensive Studies and Clinical Sessions packages. All attendees may attend these thought-provoking and highly educational sessions. However, if you are board-certified, you must purchase the package(s) for your specialty to receive the recertification assessment and claim the recertification credit.

This presentation on the 2023 atrial fibrillation (AF) guidelines will provide clinical pharmacists with an up-to-date understanding of the latest guidance on the management of patients with atrial fibrillation. Atrial fibrillation poses a significant challenge due to its association with increased stroke risk, heart failure, and other cardiovascular complications.

There have been some notable changes to these guidelines compared to the previously established 2014 guidelines with updates in 2019. This presentation will ensure pharmacists are equipped with the latest evidence-based strategies for optimal patient care. These updated guidelines include the “Top 10 Take-Home Messages.” This presentation will highlight the most relevant information for ambulatory care clinicians, specifically the new classification stages of AF, the importance of early rhythm control, thromboembolism prevention, catheter ablation moving to a class 1 indication even before medication therapy in select patients, and risk factor modification and prevention.

This activity is approved for Board-Certified Ambulatory Care Pharmacist (BCACP) recertification credit.